We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Bioprinting Studies How Cancer Cells Grow and Spread

By LabMedica International staff writers
Posted on 26 Feb 2019
Novel use of a three-dimensional (3D) bioprinting technique has created new ways to study how cancer cells grow and spread.

Investigators at the University of Minnesota (Minneapolis/St. More...
Paul, USA) have developed three-dimensional bioprinting techniques that have been adapted to build tumor constructs via precise placement of living cells, functional biomaterials, and programmable release capsules.

Three-dimensional bioprinting combines cells, growth factors, and biomaterials to fabricate biomedical constructs that maximally imitate natural tissue characteristics. Generally, three-dimensional bioprinting utilizes the layer-by-layer method to deposit biological materials to create tissue-like structures. Emerging innovations include bioprinting of cells or extracellular matrix deposited into a three-dimensional gel layer by layer to produce the desired tissue or organ.

The technique described in the January 21, 2019, online edition of the journal Advanced Materials enabled the spatiotemporal control of signaling molecular gradients, thereby dynamically modulating cellular behaviors at a local level.

Vascularized tumor models were created to mimic key steps of cancer dissemination (invasion, intravasation, and angiogenesis), based on guided migration of tumor cells and endothelial cells in the context of stromal cells and growth factors. In addition, the investigators described the benefits of using these metastatic models for drug screening by evaluating the anticancer efficacy of immunotoxins.

“This model is more consistent with what the body is like,” said senior author Dr. Angela Panoskaltsis-Mortari, professor of pediatrics at the University of Minnesota, “and, therefore, studying the effects of drugs with human cells at this level makes the results more meaningful and predictive of what will happen in the body.”

Related Links:
University of Minnesota


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
New
Portable POCT Blood Gas Analyzer
BD100
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Lead author Professor Chamindie Punyadeera. (Image Credit: Griffith University)

Breath Analysis Shows Promise for Distinguishing Cancerous from Benign Lung Nodules

Lung nodules are frequently detected during imaging, but distinguishing malignant from benign findings can require invasive procedures. Some patients undergo biopsies, bronchoscopy, or surgery before learning... Read more

Microbiology

view channel
Image: The clearance also broadens QIAstat-Dx\'s infectious disease testing menu in the U.S., which already includes panels for respiratory and gastrointestinal infections, as well as meningitis and encephalitis (Photo courtesy of Qiagen)

One-Hour Molecular Panel Expands Bloodstream Infection Testing for Gram-Negative Pathogens

Bloodstream infections can progress rapidly and lead to sepsis, organ failure, and death. In the United States, about 1.7 million adults develop sepsis each year, and at least 350,000 die during hospitalization... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.